Esophageal Cancer
📧 Sign up to get email alerts when something new happens for Esophageal Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Proton Beam Therapy (PBT) Versus Intensity-Modulated Radiation Therapy (IMRT) Trial [Phase 2]
Clinical trial update showing a Phase 2 study at MD Anderson Cancer Center comparing proton beam therapy to intensity-modulated radiation th…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients
A retrospective clinical study conducted by Nanfang Hospital/Southern Medical University evaluates prognostic factors in esophageal cancer p…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Outcomes After Esophagectomy With a Focus on Minimally Invasive Esophagectomy and Quality of Life
This entry reports on a clinical trial evaluating outcomes after esophagectomy, with emphasis on minimally invasive techniques and quality o…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: Esophageal Cancer Risk Registry
A recruiting clinical trial at the University of Pittsburgh aims to establish an Esophageal Cancer Risk Registry and study links with GERD a…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Quantitative Fluorescence Endoscopy Using Durvalumab-680LT in Esophageal Cancer [Phase 1]
Phase 1 study evaluating quantitative fluorescence endoscopy with a durvalumab-680LT conjugate in esophageal cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Real-time Activity Monitoring to Prevent Admissions During RadioTherapy [NA]
A completed clinical trial evaluating real-time activity monitoring to reduce hospital admissions during radiotherapy in cancers of the head…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study of LY4101174 in participants with recurrent, advanced or metastatic solid tumors is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer [Phase 1]
This Clinical Trial Update describes a Phase 1 study evaluating the addition of BAY 1895344 to standard chemotherapy (cisplatin or cisplatin…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: National Cancer Institute "Cancer Moonshot Biobank"
National Cancer Institute's Cancer Moonshot Biobank update outlines the trial's status and scope, indicating the study is active but not rec…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: The Vanguard Study: Testing a New Way to Screen for Cancer [NA]
The Vanguard Study is a National Cancer Institute–sponsored cancer screening trial that is currently recruiting to evaluate a new screening …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan [Phase 1]
Phase 1 trial evaluating the safety, adverse events, and pharmacokinetics of Azirkitug alone or in combination with Budigalimab, Bevacizumab…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction [Phase 1]
Phase 1 trial evaluating veliparib, paclitaxel, and carboplatin in patients with various metastatic or unresectable solid tumors and liver o…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Phase 1/1b Study of IAM1363 in HER2 Cancers [Phase 1]
IAM1363 is being studied in a Phase 1/1b trial for HER2-related cancers, and the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy [Phase 1]
This Phase 1 trial update describes evaluating ropidoxuridine as a radiosensitizer in patients with advanced gastrointestinal cancers underg…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced, Unresectable Recurrent, or Metastatic Esophageal Carcinoma [Phase 3]
Phase 3 trial evaluating atezolizumab plus tiragolumab with paclitaxel and cisplatin as first-line therapy in unresectable or metastatic eso…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors [Phase 2]
Phase 2 study evaluating futibatinib in combination with a PD-1 antibody-based standard of care for locally advanced unresectable or metasta…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors [Phase 2]
Jazz Pharmaceuticals is conducting a Phase 2 trial of Zanidatamab in HER2-expressing tumors across multiple cancers. The study is currently …
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Nutrition Intervention Trials in Linxian Follow-up Study
This update reports the completion of nutrition intervention trials within the Linxian follow-up study on esophageal and gastric cancer, spo…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer [Phase 2]
Phase 2 clinical trial update for liposomal irinotinecan with carboplatin or oxaliplatin in esophageal cancer; the study is active but not r…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A clinical trial is enrolling people with and without cancer to collect blood samples and evaluate tests for early cancer detection across m…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) [Phase 1]
Phase 1 study of ADP-A2M4CD8 as monotherapy or in combination with nivolumab or pembrolizumab in HLA-A2+ patients with MAGE-A4-positive tumo…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors [Phase 1]
Pfizer's Phase 1 study PF-08046876 is recruiting adults with various advanced solid tumors to evaluate safety and dosing. The trial includes…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: Esophageal Cancer in Northeastern Iran
The clinical trial NCT00450788 on esophageal cancer in Northeastern Iran has completed; the update does not provide trial results in the sni…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric [NA]
Update on the POP-UP trial, a single-arm, two-cohort study evaluating an 8-week trimodal prehabilitation program for patients with pancreati…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Longitudinal Study on the Evolution Trend and Influencing Factors of Postoperative Reflux of Esophageal Cancer Based on PEPTEST Technique
Ongoing longitudinal clinical trial evaluating evolution and factors influencing postoperative reflux after esophageal cancer surgery using …